CD4 T-CELL SUBSETS RESPOND DIFFERENTLY TO LATENCY REVERSAL AGENTS
Several pharmaceutical compounds as the Latency reversal agents (LRAs) can reactivate HIV expression from infected cells and might help to reduce the pool of latently infected CD4 T cells. However, the capacity of the LRAs to reactivate all infected CD4 T subpopulations is currently unknown. Viral reactivation assays were performed using freshly-isolated CD4+T cells obtained…